Alkem launches novel antibiotic for MDR infections

Alkem (Intenza, critical care division) announced the launch of its novel anti-infective in India under the brand name Zidavi. The newly launched antibiotic for multiple drug resistance (MDR) infections is in line with the company’s endeavour to...

Slovenian firm Krka eyeing promoter stake in Unichem

Slovenian pharmaceutical firm Krka, d. d., Novo mesto is in discussions to acquire the promoter’s stake in Mumbai-based Unichem Laboratories, said two people aware of the development.

Five Technology Trends that are Revolutionizing Drug Discovery

You are probably familiar with some of the biggest technology trends out there: artificial intelligence, the Internet of Things, 5G, etc.

Dupixent from Sanofi and Regeneron receives fresh EU regulatory approval

Healthcare firm Sanofi and Regeneron said on Friday the European Union's medicines regulator had given a new stage of approval for their Dupixent product to treat children as young as six months old with severe atopic dermatitis...

Incovacc,World's first nasal vaccine, in private hospitals from next week

Bharat Biotech's Incovacc, the world's first nasal Covid-19 vaccine, will be offered in private hospitals in the country starting next week. Mansukh Mandaviya, Union Health Minister, launched Incovacc on Thursday...

Paracetamol producer Granules India posts 23 per cent rise in Q3 profit

Pharmaceutical firm Granules India Ltd, reported a 23 per cent rise in third-quarter profit on Tuesday, propelled by strong demand for the painkiller drug Paracetamol. Consolidated profit rose to 1.24 billion rupees ($15.22 million) for the three...

Serum Institute of India launches first made-in-India HPV vaccine for cervical cancer

Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Tuesday announced the launch of the first made-in-India Human Papillomavirus (HPV) "CERVAVAC" vaccine, for the prevention of cervical cancer...

Amrita Hospital Faridabad launched a specialist clinic for patients with severe asthma.

Amrita Hospital Faridabad has developed a specialist clinic where persons with severe asthma will receive concentrated care and access to the latest therapies available in order to improve their quality of life...

Glenmark introduces AKYNZEO I.V. to prevent chemotherapy-induced nausea

Glenmark Pharmaceuticals Ltd announced today the launch of AKYNZEO I.V, a drug used to prevent chemotherapy-induced nausea and vomiting, in India and Nepal through an exclusive licencing agreement with Helsinn, a Swiss biopharma company...

© 2025 India Pharma Outlook. All Rights Reserved.